相似文献
1
Regenerative medicine for the heart: perspectives on stem-cell therapy.
Antioxid Redox Signal. 2014 Nov 10;21(14):2018-31. doi: 10.1089/ars.2014.6063. Epub 2014 Sep 22.
2
Harnessing cell pluripotency for cardiovascular regenerative medicine.
Nat Biomed Eng. 2018 Jun;2(6):392-398. doi: 10.1038/s41551-018-0244-8. Epub 2018 Jun 11.
3
Cardiac stem cells: biology and clinical applications.
Antioxid Redox Signal. 2014 Nov 10;21(14):2002-17. doi: 10.1089/ars.2014.5875. Epub 2014 Apr 10.
4
Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
Differentiation. 2020 Mar-Apr;112:58-66. doi: 10.1016/j.diff.2019.12.001. Epub 2020 Jan 10.
5
Regenerative Neurology and Regenerative Cardiology: Shared Hurdles and Achievements.
Int J Mol Sci. 2022 Jan 13;23(2):855. doi: 10.3390/ijms23020855.
6
Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
Can J Cardiol. 2014 Nov;30(11):1279-87. doi: 10.1016/j.cjca.2014.06.023. Epub 2014 Jul 2.
7
Induced pluripotent stem cells for cardiac repair.
Cell Mol Life Sci. 2012 Oct;69(19):3285-99. doi: 10.1007/s00018-012-1078-2. Epub 2012 Jul 20.
8
Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells.
Int J Mol Sci. 2024 May 26;25(11):5772. doi: 10.3390/ijms25115772.
9
The march of pluripotent stem cells in cardiovascular regenerative medicine.
Stem Cell Res Ther. 2018 Jul 27;9(1):201. doi: 10.1186/s13287-018-0947-5.
10
Stem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine.
Antioxid Redox Signal. 2021 Jul 20;35(3):143-162. doi: 10.1089/ars.2020.8193. Epub 2020 Nov 12.
引用本文的文献
1
Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease.
Stem Cells Int. 2023 Nov 22;2023:6500831. doi: 10.1155/2023/6500831. eCollection 2023.
2
Advancing cardiac regeneration through 3D bioprinting: methods, applications, and future directions.
Heart Fail Rev. 2024 May;29(3):599-613. doi: 10.1007/s10741-023-10367-6. Epub 2023 Nov 9.
3
Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration.
J Mol Cell Cardiol. 2022 Aug;169:13-27. doi: 10.1016/j.yjmcc.2022.04.017. Epub 2022 May 12.
4
Maturing heart muscle cells: Mechanisms and transcriptomic insights.
Semin Cell Dev Biol. 2021 Nov;119:49-60. doi: 10.1016/j.semcdb.2021.04.019. Epub 2021 May 2.
5
CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes.
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):708-720. doi: 10.1007/s00259-020-05087-0. Epub 2020 Nov 20.
6
Differentiation of brown adipose-derived stem cells into cardiomyocyte-like cells is regulated by a combination of low 5-azacytidine concentration and bone morphogenetic protein 4.
Int J Clin Exp Pathol. 2018 Nov 1;11(11):5514-5524. eCollection 2018.
7
Naturally-Derived Biomaterials for Tissue Engineering Applications.
Adv Exp Med Biol. 2018;1077:421-449. doi: 10.1007/978-981-13-0947-2_23.
8
Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells.
Tuberc Respir Dis (Seoul). 2019 Apr;82(2):158-165. doi: 10.4046/trd.2018.0044. Epub 2018 Sep 28.
9
Interfacial tissue engineering of heart regenerative medicine based on soft cell-porous scaffolds.
J Thorac Dis. 2018 Jul;10(Suppl 20):S2333-S2345. doi: 10.21037/jtd.2018.01.117.
10
β1-integrin is a cell-autonomous factor mediating the Numb pathway for cardiac progenitor maintenance.
Biochem Biophys Res Commun. 2018 Jun 2;500(2):256-260. doi: 10.1016/j.bbrc.2018.04.054. Epub 2018 Apr 13.
本文引用的文献
1
Precardiac deletion of Numb and Numblike reveals renewal of cardiac progenitors.
Elife. 2014 Apr 24;3:e02164. doi: 10.7554/eLife.02164.
2
Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells.
Circ Cardiovasc Genet. 2013 Dec;6(6):624-33. doi: 10.1161/CIRCGENETICS.113.000330. Epub 2013 Oct 18.
3
The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function.
Biomaterials. 2014 Jan;35(1):133-42. doi: 10.1016/j.biomaterials.2013.09.085. Epub 2013 Oct 4.
4
A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.
Nat Cell Biol. 2013 Sep;15(9):1098-106. doi: 10.1038/ncb2824. Epub 2013 Aug 25.
5
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair.
Cell. 2013 Aug 15;154(4):827-42. doi: 10.1016/j.cell.2013.07.039.
6
Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells.
Nat Commun. 2013;4:2307. doi: 10.1038/ncomms3307.
7
Hippo pathway effector Yap promotes cardiac regeneration.
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13839-44. doi: 10.1073/pnas.1313192110. Epub 2013 Aug 5.
8
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):E3281-90. doi: 10.1073/pnas.1303669110. Epub 2013 Aug 5.
9
Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain.
Cardiovasc Res. 2013 Oct 1;100(1):105-13. doi: 10.1093/cvr/cvt167. Epub 2013 Jun 20.
10
Homing of stem cells to ischemic myocardium.
Am J Transl Res. 2013 May 24;5(4):404-11. Print 2013.
Zotero 插件